Trials / Completed
CompletedNCT04548427
Study to Evaluate the Efficacy and Safety of CKD-352
Active Controlled, Randomized, Double-blind, Multi-center, Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-352 Eye Drops in Patients With Dry Eye Disease
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 283 (actual)
- Sponsor
- Chong Kun Dang Pharmaceutical · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the efficacy and safety of CKD-352 in patients with dry eye disease
Detailed description
Active controlled, randomized, double-blind, multi-center, phase 3 trial to evaluate the efficacy and safety of CKD-352 eye drops in patients with dry eye disease
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CKD-352 | Eye Drop |
| DRUG | Diquafosol Sodium 3% | Eye Drop |
Timeline
- Start date
- 2020-09-22
- Primary completion
- 2021-05-07
- Completion
- 2021-05-07
- First posted
- 2020-09-14
- Last updated
- 2021-06-01
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04548427. Inclusion in this directory is not an endorsement.